Back to Search
Start Over
PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells
- Source :
- Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-18 (2021), Journal of Experimental & Clinical Cancer Research : CR
- Publication Year :
- 2021
- Publisher :
- BMC, 2021.
-
Abstract
- Background Progesterone receptor membrane component 1 (PGRMC1) is a heme-binding protein inducing dimerization with cytochrome P450, which mediates chemoresistance. Increased PGRMC1 expression is found in multiple types of resistant cancers, but the role of PGRMC1 in the ferroptosis of cancer cells remains unrevealed. Therefore, we examined the role of PGRMC1 in promoting ferroptosis in paclitaxel-tolerant persister cancer cells (PCC). Methods The effects of ferroptosis inducers and PGRMC1 gene silencing/overexpression were tested on head and neck cancer (HNC) cell lines and mouse tumor xenograft models. The results were analyzed about cell viability, death, lipid ROS and iron production, mRNA/protein expression and interaction, and lipid assays. Results PCC had more free fatty acids, lipid droplets, and fatty acid oxidation (FAO) than their parental cells. PCC was highly sensitive to inhibitors of system xc− cystine/glutamate antiporter (xCT), such as erastin, sulfasalazine, and cyst(e)ine deprivation, but less sensitive to (1S,3R)-RSL3. PGRMC1 silencing in PCC reduced ferroptosis sensitivity by xCT inhibitors, and PGRMC1 overexpression in parental cells increased ferroptosis by xCT inhibitors. Lipid droplets were degraded along with autophagy induction and autophagosome formation by erastin treatment in PCC. Lipophagy was accompanied by increased tubulin detyrosination, which was increased by SIRT1 activation but decreased by SIRT1 inhibition. FAO and lipophagy were also promoted by the interaction between lipid droplets and mitochondria. Conclusion PGRMC1 expression increased FAO and ferroptosis sensitivity from in vivo mice experiments. Our data suggest that PGRMC1 promotes ferroptosis by xCT inhibition in PCC. Supplementary Information The online version contains supplementary material available at 10.1186/s13046-021-02168-2.<br />Condensed abstract Paclitaxel-tolerant persister cancer cells (PCC) had PGRMC1 upregulation related to increased free fatty acids, lipid droplets, and fatty acid oxidation. PGRMC1 expression substantially increased ferroptosis by xCT inhibition via lipophagy and tubulin detyrosination, whereas PGRMC1 silencing decreased ferroptosis: this suggests that PGRMC1 expression promotes ferroptosis in PCC. Supplementary Information The online version contains supplementary material available at 10.1186/s13046-021-02168-2.
- Subjects :
- Male
Cancer Research
Paclitaxel
Mice, Nude
Lipophagy
Mitochondrion
Transfection
Mice
Downregulation and upregulation
Cell Line, Tumor
Lipid droplet
Autophagy
Animals
Humans
Ferroptosis
Viability assay
PGRMC1
RC254-282
Chemistry
Tubulin detyrosination
Research
Membrane Proteins
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Progesterone receptor membrane component 1
Antineoplastic Agents, Phytogenic
Cell biology
Oncology
Apoptosis
Fatty acid oxidation
Cancer cell
Receptors, Progesterone
Subjects
Details
- Language :
- English
- ISSN :
- 17569966
- Volume :
- 40
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Journal of Experimental & Clinical Cancer Research
- Accession number :
- edsair.doi.dedup.....96a6638b45e06cd6414b8f14d73f4d01